Enoxaparin Sodium Injection
Product Images NDC 55154-3540

This text describes the composition and structure of a polysaccharide chain, indicating the presence of COONa and OH groups. It also mentions percentages of certain derivatives, including 1,6 anhydro derivative, at the reducing end of the polysaccharide chain. The text also includes chemical formulas for some of the components.*

This appears to be a list of categories and binary responses for medical data, including information about patients' sex, age, location of infarct, medical history (including diabetes and prior MI), treatment received (including fibrinolytic agents and time to treatment), and clinical outcomes. It is likely a dataset from a research study or clinical trial.*

This is a description of Enoxaparin Sodium Injection, USP, which is a medication used for subcutaneous injection. The package comes with five single-dose syringes, each containing 30 mg of enoxaparin sodium injection derived from porcine intestinal mucosa in Water for Injection. Instructions for dosage and administration can be found in the product insert. The medication should be stored at a controlled room temperature between 20° and 25° G (68° to 77" F|). This product is not child-resistant and is intended for institutional use only. The safety system is activated by pushing the plunger rod and is designed to protect against accidental needlestick injuries. After use, the syringe should be immediately disposed of in the nearest sharps container. Activation of the safety system may cause minimal splatter, and the system should be activated while oriented downwards away from yourself and others.*

This is a description of a package of Enoxaparin Sodium Injection, USP, containing six single-dose syringes, each syringe containing 40mg of the injection, used for subcutaneous injection. The dosage and administration should be made according to the product insert for dosage information and directions. The package is manufactured in China by Shenzhen Techdow Pharmaceutical Co., Lid, and distributed by Cardinal Health. The syringes come with an automatic safety device, which should be activated immediately after the injection to dispose of the syringe in a sharps container. The syringe should be kept out of the reach of children, and the safety system should be activated away from oneself and others.*

This is a product description of Enoxaparin Sodium Injection, USP. It is a 80mg /0.6 mL injection used for subcutaneous injection. The package contains 5 single-use syringes with automatic safety device designed for Institutional Use Only. The drug must be kept at a controlled room temperature of 20°25° C (6877 F). The package contains a warning that it is not child-resistant and should be kept out of children's reach. It also gives instructions for use and activation of the safety system on the syringe. The manufacturer is Shenzhen Techdow Pharmaceutical Co, Ltd, and it's distributed by Cardinal Health.*

This text describes a medication called Enoxaparin Sodium Injection, which is delivered in single-dose syringes with an automatic safety device for subcutaneous injection. Each syringe has 80 mg of the medication, and the package comes with 5 0.8 mL syringes. The text also provides dosage and administration instructions and warns against child access to the medication. The injection comes from Shenzhen Techdow Pharmaceutical Co, Ltd and is distributed by Cardinal Health for Sandoz Inc. The text contains directions for use of the syringes and how to activate the safety system. The medication should be stored at 20°C to 25°C.*

This is a description of a single dose syringe of Enoxaparin Sodium Injection, which is derived from porcine intestinal mucosa in Water for Injection. It's mainly used for subcutaneous injection for patients. The injection contains 100 mg Enoxaparin sodium that is given according to the prescription to the patient. The syringe has an automatic safety system, and after the injection, the protective sleeve covers the needle with an audible click to confirm that the safety has been activated. The syringe should be discarded immediately after injection in a sharps container. The drug must be stored at 68°-77°F, and the package is not intended for child-resistant. It is solely for institutional use only. The syringes are manufactured by Shenzhen Techdow Pharmaceutical and are distributed by Cardinal Health, and Sandoz Inc.*